Search Results

There are 5851 results for: content related to: Conversion to everolimus in maintenance liver transplant patients: A multicenter, retrospective analysis

  1. You have full text access to this OnlineOpen article
    Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma – systematic review and meta-analysis

    Cancer Medicine

    Volume 2, Issue 6, December 2013, Pages: 862–871, Kenya Yamanaka, Marius Petrulionis, Shibo Lin, Chao Gao, Uwe Galli, Susanne Richter, Susanne Winkler, Philipp Houben, Daniel Schultze, Etsuro Hatano and Peter Schemmer

    Article first published online : 22 OCT 2013, DOI: 10.1002/cam4.150

  2. You have free access to this content
    Mechanisms of Everolimus-Induced Glomerulosclerosis After Glomerular Injury in the Rat

    American Journal of Transplantation

    Volume 5, Issue 12, December 2005, Pages: 2849–2861, C. Daniel, L. Renders, K. Amann, E. Schulze-Lohoff, I.A. Hauser and C. Hugo

    Article first published online : 18 NOV 2005, DOI: 10.1111/j.1600-6143.2005.01120.x

  3. Influence of Everolimus on Steady-State Pharmacokinetics of Cyclosporine in Maintenance Renal Transplant Patients

    The Journal of Clinical Pharmacology

    Volume 45, Issue 7, July 2005, Pages: 781–791, Dr Klemens Budde, Dr Gustav Lehne, Dr Michael Winkler, Dr Lutz Renders, Dr Arno Lison, Dr Lutz Fritsche, Dr Jean-Paul Soulillou, Dr Per Fauchald, Dr Hans-Hellmut Neumayer, Dr Jaques Dantal and Behalf of the RADW 102 Renal Transplant Study Group

    Article first published online : 25 MAR 2013, DOI: 10.1177/0091270005277196

  4. You have free access to this content
    Improved Renal Function After Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation

    American Journal of Transplantation

    Volume 12, Issue 10, October 2012, Pages: 2744–2753, L. Mjörnstedt, S. S. Sørensen, B. von zur Mühlen, B. Jespersen, J. M. Hansen, C. Bistrup, H. Andersson, B. Gustafsson, L.H. Undset, H. Fagertun, D. Solbu and H. Holdaas

    Article first published online : 19 JUL 2012, DOI: 10.1111/j.1600-6143.2012.04162.x

  5. You have free access to this content
    Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3-Year Results From the Randomized ZEUS Study

    American Journal of Transplantation

    Volume 12, Issue 6, June 2012, Pages: 1528–1540, K. Budde, F. Lehner, C. Sommerer, W. Arns, P. Reinke, U. Eisenberger, R. P. Wüthrich, S. Scheidl, C. May, E.-M. Paulus, A. Mühlfeld, H. H. Wolters, K. Pressmar, R. Stahl, O. Witzke and On behalf of the ZEUS Study Investigators

    Article first published online : 5 MAR 2012, DOI: 10.1111/j.1600-6143.2012.03994.x

    Corrected by:

    Erratum

    Vol. 12, Issue 11, 3165, Article first published online: 27 OCT 2012

  6. Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases

    Annals of the New York Academy of Sciences

    Volume 1291, Issue 1, July 2013, Pages: 14–32, David Lebwohl, Özlem Anak, Tarek Sahmoud, Judith Klimovsky, Ingrid Elmroth, Tomas Haas, Joseph Posluszny, Stephen Saletan and William Berg

    Article first published online : 9 MAY 2013, DOI: 10.1111/nyas.12122

  7. You have free access to this content
    Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsA in Renal-Transplant Recipients

    American Journal of Transplantation

    Volume 10, Issue 6, June 2010, Pages: 1401–1413, H. Tedesco Silva Jr., D. Cibrik, T. Johnston, E. Lackova, K. Mange, C. Panis, R. Walker, Z. Wang, G. Zibari and Y. S. Kim

    Article first published online : 28 APR 2010, DOI: 10.1111/j.1600-6143.2010.03129.x

  8. You have free access to this content
    A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation—PROTECT

    American Journal of Transplantation

    Volume 12, Issue 7, July 2012, Pages: 1855–1865, L. Fischer, J. Klempnauer, S. Beckebaum, H. J. Metselaar, P. Neuhaus, P. Schemmer, U. Settmacher, N. Heyne, P-A. Clavien, F. Muehlbacher, I. Morard, H. Wolters, W. Vogel, T. Becker, M. Sterneck, F. Lehner, C. Klein, G. Kazemier, A. Pascher, J. Schmidt, F. Rauchfuss, A. Schnitzbauer, S. Nadalin, M. Hack, S. Ladenburger and H. J. Schlitt

    Article first published online : 11 APR 2012, DOI: 10.1111/j.1600-6143.2012.04049.x

  9. Everolimus: A Proliferation Signal Inhibitor with Clinical Applications in Organ Transplantation, Oncology, and Cardiology

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 10, October 2010, Pages: 1044–1056, Steven Gabardi and Steven A. Baroletti

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.30.10.1044

  10. You have free access to this content
    Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial

    American Journal of Transplantation

    Volume 13, Issue 5, May 2013, Pages: 1203–1216, H. J. Eisen, J. Kobashigawa, R. C. Starling, D. F. Pauly, A. Kfoury, H. Ross, S.-S. Wang, B. Cantin, A. Van Bakel, G. Ewald, S. Hirt, H. Lehmkuhl, A. Keogh, M. Rinaldi, L. Potena, A. Zuckermann, G. Dong, C. Cornu-Artis and P. Lopez

    Article first published online : 22 FEB 2013, DOI: 10.1111/ajt.12181

  11. You have free access to this content
    Virtual Histology Assessment of Cardiac Allograft Vasculopathy Following Introduction of Everolimus—Results of a Multicenter Trial

    American Journal of Transplantation

    Volume 12, Issue 10, October 2012, Pages: 2700–2709, S. Arora, I. Erikstad, T. Ueland, V. Sigurdardottir, B. Ekmehag, K. Jansson, H. Eiskjær, H. E. Bøtker, S.-A. Mortensen, K. Saunamaki, E. Gude, A. Ragnarsson, D. Solbu, P. Aukrust and L. Gullestad

    Article first published online : 7 SEP 2012, DOI: 10.1111/j.1600-6143.2012.04234.x

  12. Everolimus: Targeted Therapy on the Horizon for the Treatment of Breast Cancer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 4, April 2012, Pages: 383–396, Chad M. Barnett

    Article first published online : 27 MAR 2012, DOI: 10.1002/j.1875-9114.2012.01084.x

  13. You have free access to this content
    Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial

    Liver Transplantation

    Volume 15, Issue 10, October 2009, Pages: 1262–1269, Paolo De Simone, Herold J. Metselaar, Lutz Fischer, Jérôme Dumortier, Karim Boudjema, Jean Hardwigsen, Lionel Rostaing, Luciano De Carlis, Faouzi Saliba and Frederik Nevens

    Article first published online : 29 SEP 2009, DOI: 10.1002/lt.21827

  14. You have free access to this content
    Phase 3 trial of everolimus for metastatic renal cell carcinoma

    Cancer

    Volume 116, Issue 18, 15 September 2010, Pages: 4256–4265, Robert J. Motzer, Bernard Escudier, Stephane Oudard, Thomas E. Hutson, Camillo Porta, Sergio Bracarda, Viktor Grünwald, John A. Thompson, Robert A. Figlin, Norbert Hollaender, Andrea Kay, Alain Ravaud and for the RECORD-1 Study Group

    Article first published online : 19 AUG 2010, DOI: 10.1002/cncr.25219

  15. Fibrosis progression in maintenance liver transplant patients with hepatitis C recurrence: a randomised study of everolimus vs. calcineurin inhibitors

    Liver International

    Federico G. Villamil, Adrian C. Gadano, Fernanda Zingale, Roberto Perez, Octavio Gil, Silvina Yantorno, Ricardo Mastai, Fernando O. Cairo, Alcira B. Otero, Gaohong Dong, Patricia Lopez and on behalf of the REVERT Study Group

    Article first published online : 15 DEC 2013, DOI: 10.1111/liv.12416

  16. Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation

    Transplant Infectious Disease

    Volume 15, Issue 2, April 2013, Pages: 150–162, J. Kobashigawa, H. Ross, C. Bara, J.F. Delgado, T. Dengler, H.B. Lehmkuhl, S.-S. Wang, G. Dong, S. Witte, G. Junge and L. Potena

    Article first published online : 26 SEP 2012, DOI: 10.1111/tid.12007

  17. You have free access to this content
    Therapeutic Drug Monitoring for Everolimus in Heart Transplant Recipients Based on Exposure–Effect Modeling

    American Journal of Transplantation

    Volume 4, Issue 12, December 2004, Pages: 2126–2131, Randall C. Starling, Joshua M. Hare, Paul Hauptman, Kenneth R. McCurry, Hartmut W. Mayer, John M. Kovarik and Heinz Schmidli

    Article first published online : 4 OCT 2004, DOI: 10.1046/j.1600-6143.2004.00601.x

  18. You have full text access to this Open Access content
    Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells

    Cancer Science

    Volume 103, Issue 9, September 2012, Pages: 1665–1671, Mayu Yunokawa, Fumiaki Koizumi, Yuka Kitamura, Yasufumi Katanasaka, Naoko Okamoto, Makoto Kodaira, Kan Yonemori, Chikako Shimizu, Masashi Ando, Kenkichi Masutomi, Teruhiko Yoshida, Yasuhiro Fujiwara and Kenji Tamura

    Article first published online : 1 AUG 2012, DOI: 10.1111/j.1349-7006.2012.02359.x

  19. You have free access to this content
    Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results

    Liver Transplantation

    Volume 12, Issue 11, November 2006, Pages: 1640–1648, Gary Levy, Heinz Schmidli, Jeffrey Punch, Elizabeth Tuttle-Newhall, David Mayer, Peter Neuhaus, Didier Samuel, Bjorn Nashan, Juergen Klempnauer, Alan Langnas, Yvon Calmus, Xavier Rogiers, Michael Abecassis, Richard Freeman, Maarten Sloof, John Roberts and Lutz Fischer

    Article first published online : 5 APR 2006, DOI: 10.1002/lt.20707

  20. You have free access to this content
    Three-Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients

    American Journal of Transplantation

    Volume 5, Issue 10, October 2005, Pages: 2521–2530, Štefan Vítko, Raimund Margreiter, Willem Weimar, Jacques Dantal, Dirk Kuypers, Michael Winkler, Ole Øyen, Hendrik G. Viljoen, Pavel Filiptsev, Sami Sadek, Yulan Li, Nathalie Cretin, Klemens Budde and for the RAD B201 Study Group

    Article first published online : 11 SEP 2005, DOI: 10.1111/j.1600-6143.2005.01063.x